ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Brukinsa 80 mg, Hartkapseln - 120
67998001 BeiGene Switzerland GmbH
Brukinsa 80 mg, Hartkapseln08.02.2022
  08.02.2022
Zanubrutinib (L01EL03) 
WHO-DDD07.02.2027
07.16.10.120
07.16.10. 
A  
Yes 
IPCI
4486.72Yes
    
10 %4896.00
7680679980013Synthetika
  
Composition
zanubrutinibum 80 mg, cellulosum microcristallinum, carmellosum natricum conexum, natrii laurilsulfas, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: gelatina, E 171, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, pro capsula corresp. natrium 1.17 mg.
Packungsbestandteile
Capsules 
  
 
Active AgentDose
Zanubrutinibum80 mg
BAG: Active AgentDose
Zanubrutinibum80 mg
 
Inactive agents additional_information
(Nigrum)  
Carmellosum Natricum Conexum  
Cellulosum Microcristallinum  
E 171 color.
E 172 color.
Gelatina Kapselhülle
Lacca Drucktinte
Magnesii Stearas  
Natrii Laurilsulfas  
Propylenglycol  
Silica Colloidalis Anhydrica  
 
Source
Data was imported : 07.03.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home